A004 – Neurosciences

Research objectives
The main objective of the Neuroscience Area is to search for new therapeutic targets and improve the clinical-therapeutic management of neurological patients, mainly stroke, Alzheimer’s disease, Parkinson’s disease, headaches and neurological prion diseases.
- Identification and validation of diagnostic and therapeutic targets in neurological diseases
- Treatment of neurological diseases caused by prions
- Study and treatment of nervous system tumors
- The creation and application of new drugs
- Cell and gene therapy
- Study of the cellular and molecular mechanisms involved in neurological diseases
- Nanomedicine applied to Neurosciences
- Promotion and development of clinical trials in early phases
- Development of clinical practice guidelines in neurological diseases
Research groups
Area leader
Area co-leader
Francisco Campos Pérez
El Dr. Francisco Campos hizo su formación postdoctoral en IIBB-CSIC (Barcelona) (2007-08), en el Instituto de Investigaciones Sanitarias de Santiago de Compostela (IDIS) (2009-10) y Massachusetts General Hospital-Harvard Medical School (2011-12). Desde 2013 es investigador Miguel Servet. Es autor d